Arun Sundaram Talks CFRA Walgreens Report
Arun Sundaram explains that Walgreens will be selling the majority of their pharmaceutical wholesale business. He thinks Walgreens is getting more aggressive in its long-term strategic plan. He feels Walgreens is a value stock but keeps a hold rating on the stock. He thinks the vaccine should drive store sales.
ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US

Arun Sundaram Talks CFRA Walgreens Report
Arun Sundaram explains that Walgreens will be selling the majority of their pharmaceutical wholesale business. He thinks Walgreens is getting more aggressive in its long-term strategic plan. He feels Walgreens is a value stock but keeps a hold rating on the stock. He thinks the vaccine should drive store sales.
ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US